Effects of new inotropic agents on cyclic nucleotide metabolism and calcium transients in canine ventricular muscle

scientific article published on 01 March 1986

Effects of new inotropic agents on cyclic nucleotide metabolism and calcium transients in canine ventricular muscle is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID2417745

P2093author name stringEndoh M
Taira N
Yanagisawa T
Blinks JR
P433issue3 Pt 2
P407language of work or nameEnglishQ1860
P304page(s)III117-33
P577publication date1986-03-01
P1433published inCirculationQ578091
P1476titleEffects of new inotropic agents on cyclic nucleotide metabolism and calcium transients in canine ventricular muscle
P478volume73

Reverse relations

cites work (P2860)
Q35007243A low-dose β1-blocker in combination with milrinone improves intracellular Ca2+ handling in failing cardiomyocytes by inhibition of milrinone-induced diastolic Ca2+ leakage from the sarcoplasmic reticulum
Q43600533A multicenter study of a new inotropic agent, piperanometozine (OPC-8212) in congestive heart failure: clinical improvement during short-term treatment
Q68073754A new cardiotonic agent, OPC-8212, elevates the myocardial oxygen consumption versus pressure-volume area (PVA) relation in a similar manner to catecholamines and calcium in canine hearts
Q44078545Acute and long-term hemodynamic response to low-dose enoximone in refractory heart failure
Q42011402An analysis of the mechanism of the inotropic action of some milrinone analogues in guinea-pig isolated atria
Q36932457Cellular and ionic mechanisms underlying the effects of cilostazol, milrinone, and isoproterenol to suppress arrhythmogenesis in an experimental model of early repolarization syndrome.
Q37302824Cellular mechanisms underlying the effects of milrinone and cilostazol to suppress arrhythmogenesis associated with Brugada syndrome
Q68424322Comparative effects of enoximone and theophylline on plasma catecholamines and haemodynamics in cardiosurgical patients
Q67685677Comparison between the cardiac effects induced by muzolimine and furosemide in guinea-pig atria
Q67691488Comparison of cyclic nucleotide phosphodiesterase isoenzymes in rat and rabbit ventricular myocardium: positive inotropic and phosphodiesterase inhibitory effects of Org 30029, milrinone and rolipram
Q41584608Could Ca2+ sensitizers rescue patients from chronic congestive heart failure?
Q69242850Differential effects of reoxygenation on intracellular calcium and isometric tension
Q42607945Does levosimendan act as Ca(2+) sensitizer or PDE3 inhibitor?
Q68077867Effects of a new 1,3-thiazole derivative ZSY-39 on force of contraction and cyclic AMP content in canine ventricular muscle
Q41875562Effects of cAMP modulators on long-chain fatty-acid uptake and utilization by electrically stimulated rat cardiac myocytes
Q46154248Incidence of milrinone blood levels outside the therapeutic range and their relevance in children after cardiac surgery for congenital heart disease
Q46761465Involvement of purine compounds in the inotropic action of milrinone
Q34534329J-Wave syndromes expert consensus conference report: Emerging concepts and gaps in knowledge
Q87886309J-Wave syndromes expert consensus conference report: Emerging concepts and gaps in knowledge
Q55059903J-Wave syndromes expert consensus conference report: Emerging concepts and gaps in knowledge.
Q26859366J-wave syndromes: Brugada and early repolarization syndromes
Q39534050Milrinone. A preliminary review of its pharmacological properties and therapeutic use.
Q44321768New milrinone analogues: in vitro study of structure-activity relationships for positive inotropic effect, antagonism towards endogenous adenosine, and inhibition of cardiac type III phosphodiesterase
Q67270678OPC-8212 in the treatment of congestive heart failure: results of a pilot study
Q46577023Positive inotropic effects of the calcium channel activator Bay K 8644 on guinea-pig and human isolated myocardium
Q42493953Regulation of force and intracellular calcium transients by cyclic AMP generated by forskolin, MDL 17,043 and isoprenaline, and its modulation by muscarinic receptor agents: a novel mechanism for accentuated antagonism
Q39148010Selective updates on mechanisms of action of positive inotropic agents
Q38303668Studies on the mechanism of action of the bipyridine milrinone on the heart
Q68257142Subcellular mechanism of the positive inotropic effect of a new quinolinone derivative OPC-8490 on the dog ventricular myocardium
Q67661700Sulmazole (AR-L 115BS) activates the sheep cardiac muscle sarcoplasmic reticulum calcium-release channel in the presence and absence of calcium
Q97526210The effect of milrinone on mortality in adult patients who underwent CABG surgery: a systematic review of randomized clinical trials with a meta-analysis and trial sequential analysis
Q67711480The effects of milrinone in the neonatal pig heart
Q68194402The inhibitory effects of a positive inotropic quinolinone derivative, 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-quinolinone (OPC-8212), on bone-marrow progenitor cells and peripheral lymphocytes
Q38215901The rationale for combined use of diuretics, digitalis, and vasodilators in congestive heart failure

Search more.